UOC
PEPL

UBS O'Connor’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

UBS O'Connor’s Portfolio PEPL Stock Details PEPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-236,311
Closed -$2.42M – 758
2022
Q4 		$2.42M Sell
236,311
-2,312
-1% -$23.3K 0.04% 373
2022
Q3 		$2.38M Sell
238,623
-23,888
-9% -$237K 0.03% 531
2022
Q2 		$2.62M Hold
262,511
– – 0.03% 517
2022
Q1 		$2.58M Buy
262,511
+4,626
+2% +$45.4K 0.03% 496
2021
Q4 		$2.53M Buy
+257,885
New +$2.52M 0.02% 485

Other funds holding PEPL

RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RCM
Robinson Capital Management Grosse Pointe Farms, Michigan $226M AUM 6.92% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return

UBS O'Connor's PEPL Position: Q1 2023 in Review

UBS O'Connor sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2023, closing a stake of 236,311 shares — an estimated $2.42M sold.

UBS O'Connor first reported a position in PEPL in Q4 2021 and held it in 5 quarters. The position peaked at $2.62M in Q2 2022. 15 funds tracked by Wall St. Rank hold PEPL as of Q1 2023.

  • UBS O'Connor reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • UBS O'Connor sold 236,311 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2023, an estimated $2.42M.
  • UBS O'Connor first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
  • UBS O'Connor's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $2.62M in Q2 2022.
  • 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.